Author reply
Despite the emphasis on randomized data to guide evidence-based practice, there is a notable lack of clinical trials to inform comparative effectiveness in surgical disciplines. Although this is multifactorial in nature, this paucity ultimately reflects the difficulty associated with conducting surgical trials, particularly in settings where event rates are low (eg, lymph node metastasis in M0 renal cell carcinoma) or when long follow-up is required, as with early-stage disease (eg, low-risk prostate cancer).
Source: Urology - Category: Urology & Nephrology Authors: Janine Bacic, Boris Gershman Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Clinical Trials | Kidney Cancer | Prostate Cancer | Renal Cell Carcinoma | Urology & Nephrology